- “Northfield Laboratories’ closing creates an opening for a new firm” (Chicago Tribune)
- “Amgen spent nearly $2.8M lobbying in 1Q” (Seattle Times)
- “AstraZeneca gets block on Apotex Pulmicort copies” (Forbes, The Associated Press)
- “Lilly Advances Second Alzheimer’s Disease Treatment Candidate Into Late-Stage Testing by Launching Two Global Trials” (Press release issued by Eli Lilly and Company, PRNewswire)
- “Decision time for Bayer and Glaxo drugs in U.S.” (Reuters)
- “Glaxo sees more big orders for H1N1 flu vaccine” (Reuters)
- “J&J seeks to arbitrate Schering Remicade deal” (The Associated Press)
- “Novartis respiratory drug improves lung function” (Reuters)
- “Pfizer’s Kindler on Health-Care Reform and the Wyeth Deal” (BusinessWeek)
THE LATEST WORD
Top Industry Stories – May 21, 2009
Posted on May 21st, 2009 | by Rxmedyn | No Comments »Posted in Industry Stories
SUBSCRIBE-
Recent Posts
Archives
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
Careers | © 2009 Medical Dynamics